A first-in-human clinical trial of RXC-004

Trial Profile

A first-in-human clinical trial of RXC-004

Planning
Phase of Trial: Phase I

Latest Information Update: 12 Sep 2017

At a glance

  • Drugs RXC 004 (Primary)
  • Indications Cancer; Gastric cancer
  • Focus Adverse reactions; First in man
  • Most Recent Events

    • 12 Sep 2017 Trial design of the study presented at the 42nd European Society for Medical Oncology Congress.
    • 02 Sep 2017 New trial record
    • 31 Aug 2017 According to a Redx Pharma media release, the company will present a poster on this planned trial at the European Society for Medical Oncology (ESMO) Annual Meeting 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top